OncoCyte Corp (NASDAQ: OCX) stock closed at $5.30 on 10/17/25 after a major increase of 14.5%. Moreover, this advance was accompanied by exceptionally high trading volume at 325% of normal. The stock has risen 39.3% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
OncoCyte is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment